Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in miceOA
Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice
Xiaowei Zhang;Zhongyong Wang;Taohui Ouyang;Brayden Wang;Richard I.Joh;Suyun Huang
Department of Human and Molecular Genetics,School of Medicine,Virginia Commonwealth University,Richmond,VA 23298,USA||Massey Cancer Center,Virginia Commonwealth University,Richmond,VA 23298,USADepartment of Neurosurgery,The University of Texas MD Anderson Cancer Center,Houston,TX 77030,USADepartment of Human and Molecular Genetics,School of Medicine,Virginia Commonwealth University,Richmond,VA 23298,USA||Massey Cancer Center,Virginia Commonwealth University,Richmond,VA 23298,USADepartment of Pharmacology and Toxicology,Virginia Commonwealth University,Richmond,VA 23298,USAMassey Cancer Center,Virginia Commonwealth University,Richmond,VA 23298,USA||Department of Physics,Virginia Commonwealth University,Richmond,VA 23219,USADepartment of Human and Molecular Genetics,School of Medicine,Virginia Commonwealth University,Richmond,VA 23298,USA||Massey Cancer Center,Virginia Commonwealth University,Richmond,VA 23298,USA
ChemoresistanceGlioblastomaTemozolomideWnt inhibitorWnt/β-catenin
ChemoresistanceGlioblastomaTemozolomideWnt inhibitorWnt/β-catenin
《基因与疾病（英文）》 2026 (1)
492-505,14
This work was supported in part by Paul M.Corman,MD Chair in Cancer Research Endowment Fund.
评论